• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Myeloproliferative Neoplasms (MF – PV – ET)

  • Imetelstat for Myelofibrosis
    January 24, 2021

    Imetelstat for Myelofibrosis

    Charles H. Weaver, MD
  • Overview of Myeloproliferative Neoplasms
    November 7, 2020

    Overview of Myeloproliferative Neoplasms

    Charles H. Weaver, MD
  • Budd-Chiari Syndrome
    October 2, 2020

    Budd-Chiari Syndrome

    Charles H. Weaver, MD
  • Jakafi Superior to Standard Therapy for Polycythemia Vera
    April 15, 2020

    Jakafi Superior to Standard Therapy for Polycythemia Vera

    Charles H. Weaver, MD
  • Understanding Allogeneic Stem Cell Transplant
    January 24, 2020

    Understanding Allogeneic Stem Cell Transplant

    Charles H. Weaver, MD
  • Inrebic (fedratinib) Treatment of Myelofibrosis
    December 30, 2019

    Inrebic (fedratinib) Treatment of Myelofibrosis

    Charles H. Weaver, MD
  • Progress on Pacritinib Development for Treatment of Myelofibrosis
    December 27, 2019

    Progress on Pacritinib Development for Treatment of Myelofibrosis

    Charles H. Weaver, MD
  • Ojjaara (momelotinib) Gets FDA Approval for Myelofibrosis
    September 17, 2019

    Ojjaara (momelotinib) Gets FDA Approval for Myelofibrosis

    Charles H. Weaver, MD
  • What you Need to Know about Itching and Myeloproliferative Neoplasms
    September 5, 2018

    What you Need to Know about Itching and Myeloproliferative Neoplasms

    Charles H. Weaver, MD
  • Symptomatic Polycythemia Vera Patients May Benefit From Treatment
    December 29, 2015

    Symptomatic Polycythemia Vera Patients May Benefit From Treatment

    Charles H. Weaver, MD
Previous Page
1 2
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
 

Loading Comments...